Chris Hodkinson, Marc van der Schee, and Hamilton Scanlon
Owlstone Medical has appointed Chris Hodkinson as vice president of business development, Marc van der Schee as lead clinical research scientist, and Hamilton Scanlon as vice president of manufacturing. Hodkinson joins Owlstone from Abcodia, which he co-founded and where he served as director and chief operating officer. Van der Schee joins the company with 10 years of experience in the field of volatile biomarker research. Scanlon joins Owlstone with over 30 years of experience in product development. He has worked at start-up companies and PLCs, and has been responsible for setting up manufacturing facilities within China, Italy, and the UK.